These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 621814)

  • 1. The cell surface antigen A, B or O(H) as an indicator of malignant potential in stage A bladder carcinoma: preliminary report.
    Bergman S; Javadpour N
    J Urol; 1978 Jan; 119(1):49-51. PubMed ID: 621814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the cell surface antigens with stage and grade in cancer of the bladder.
    Emmott RC; Javadpour N; Bergman SM; Soares T
    J Urol; 1979 Jan; 121(1):37-9. PubMed ID: 759641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface A, B, or O(H) blood group antigens as an indicator of malignant potential in stage A bladder carcinoma.
    Newman AJ; Carlton CE; Johnson S
    J Urol; 1980 Jul; 124(1):27-9. PubMed ID: 7411715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of cell surface antigens in low grade, non-invasive, transitional cell carcinoma of the bladder.
    Young AK; Hammond E; Middleton AW
    J Urol; 1979 Oct; 122(4):462-4. PubMed ID: 480485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue blood-group antigens and prognosis in low stage transitional cell carcinoma of the bladder.
    Lange PH; Limas C; Fraley EE
    J Urol; 1978 Jan; 119(1):52-5. PubMed ID: 621815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic deletion and prognosis of patients with stage A transitional cell bladder carcinoma.
    Decenzo JM; Howard P; Irish CE
    J Urol; 1975 Dec; 114(6):874-8. PubMed ID: 1195466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind comparison of T-antigen and ABO(H) cell surface antigens in bladder cancer.
    Vafier JA; Javadpour N; Worsham GF; O'Connell KJ
    Urology; 1984 Apr; 23(4):348-51. PubMed ID: 6369713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A, B, H antigens in transitional cell tumors of the urinary bladder: correlation with the clinical course.
    Limas C; Lange P; Fraley EE; Vessella RL
    Cancer; 1979 Dec; 44(6):2099-107. PubMed ID: 509389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relations of clinicopathological findings to expression of ABH blood group and Thomsen-Friedenrich antigens in initially superficial papillary transitional cell carcinomas of the bladder developing subsequent malignant progression].
    Yamada T; Fukui I; Yokogawa M; Oshima H
    Nihon Hinyokika Gakkai Zasshi; 1988 Jun; 79(6):1049-53. PubMed ID: 3184579
    [No Abstract]   [Full Text] [Related]  

  • 12. Correlation of ABH antigenicity and urine cytology results in transitional cell carcinoma of bladder.
    Gorelick JI; Oyasu R; Golmon ME; Grayhack JT
    Urology; 1984 Sep; 24(3):287-90. PubMed ID: 6474644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A, B, H antigen expression in transitional cell carcinomas of the urinary bladder.
    Juhl BR; Hartzen SH; Hainau B
    Cancer; 1986 May; 57(9):1768-75. PubMed ID: 2420436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered reactivity for A, B, H antigens in transitional cell carcinomas of the urinary bladder. A study of the mechanisms involved.
    Limas C; Lange P
    Cancer; 1980 Sep; 46(6):1366-73. PubMed ID: 7417937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell surface antigens of bladder washing specimens in patients with bladder tumors, a new approach.
    Sadoughi N; Rubenstone A; Mlsna J; Davidsohn I
    J Urol; 1980 Jan; 123(1):19-21. PubMed ID: 6985978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to detect A, B and H blood group isoantigens in superficial transitional cell carcinoma of the bladder: a means of predicting invasive recurrences.
    Stephenson TJ; Williams JL; Gelsthorpe K
    Br J Urol; 1985 Apr; 57(2):148-53. PubMed ID: 3886066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABH isoantigens in stage O papillary transitional cell carcinoma of the bladder: correlation with biological behavior.
    D'Elia FL; Cooper HS; Mulholland SG
    J Urol; 1982 Apr; 127(4):665-7. PubMed ID: 7069827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood group H antigen in transitional carcinoma of the urinary bladder.
    Tichý M; Tichá V; Jansa P; Student V; Vanák J
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():157-62. PubMed ID: 1838863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.